A detailed history of Covestor LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Covestor LTD holds 474 shares of ADMA stock, worth $7,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
474
Previous 474 -0.0%
Holding current value
$7,375
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$17.6 - $24.51 $8,113 - $11,299
461 Added 3546.15%
474 $9,000
Q1 2025

May 12, 2025

SELL
$15.44 - $20.61 $92,377 - $123,309
-5,983 Reduced 99.78%
13 $0
Q4 2024

Feb 13, 2025

BUY
$15.62 - $22.62 $92,345 - $133,729
5,912 Added 7038.1%
5,996 $103,000
Q3 2024

Nov 01, 2024

SELL
$11.21 - $20.03 $493 - $881
-44 Reduced 34.38%
84 $2,000
Q2 2024

Aug 09, 2024

BUY
$5.98 - $11.18 $765 - $1,431
128 New
128 $1,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.